諾力股份(603611.SH):子公司興諾投資斥3000萬元參設股權基金
格隆匯3月4日丨諾力股份(603611.SH)宣佈,公司全資子公司興諾投資與寧波梅山保税港區昆裕潤源資產管理有限公司(簡稱“昆裕潤源”)、其他有限合夥人簽署合夥協議,約定合作發起設立寧波逍遙股權投資合夥企業(有限合夥),基金管理人為昆裕潤源。基金規模為人民幣6.65億元,其中,興諾投資認繳金額為3000萬元,佔該基金總認繳規模的4.5113%。
該基金主要投資於中後期階段未上市公司股權,以及已有投資組合企業後續跟進股權投資等,閒置資金可投資於銀行存款、銀行理財、貨幣基金等現金管理工具。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.